Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Correlation between the anti-HIV potency of CADA derivatives and their ability to down-modulate the CD4 receptor — Kurt Vermeire (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Correlation between the anti-HIV potency of CADA derivatives and their ability to down-modulate the CD4 receptor
Shared by
De Clercq Erik
KU Leuven
Correlation between the anti-HIV potency of CADA derivatives and their ability to down-modulate the CD4 receptor
Article
2002
en
Authors
+1 more
KV
Kurt Vermeire
TB
Thomas W. Bell
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
The anti-HIV and anti-HHV-7 potency of CADA analogs is strictly correlated with their ability to down-modulate the CD4 receptor
Kurt Vermeire
,
Thomas W. Bell
,
De Clercq Erik
,
Dominique Schols
Article
2003
The Anti-HIV Potency of Cyclotriazadisulfonamide Analogs Is Directly Correlated with Their Ability to Down-Modulate the CD4 Receptor
Qi Jin
,
M Samala
,
A Sodoma
,
De Clercq Erik
,
Dominique Schols
,
Kurt Vermeire
,
Thomas W. Bell
,
Heung‐Jin Choi
Article
2004
Synthesis of novel CADA compounds and their anti-HIV and CD4 down-modulation activities
S. Anugu
,
N.H. Duffy
,
K Dey
,
Jin Qiu
,
M Samala
,
A Sodoma
,
Thomas W. Bell
,
Kurt Vermeire
,
De Clercq Erik
,
Dominique Schols
Article
2003
In vitro synergy between the CD4 down-modulating compound, CADA, and multiple anti-HIV drugs
Kurt Vermeire
,
Sigrid Hatse
,
De Clercq Erik
,
K Dey
,
M Samala
,
A Sodoma
,
Thomas W. Bell
,
Dominique Schols
Article
2002
CADA, a specific CD4 down-modulating compound with potent anti-HIV activity
Dominique Schols
,
Kurt Vermeire
,
Sigrid Hatse
,
K Dey
,
M Samala
,
A Sodoma
,
De Clercq Erik
,
Thomas W. Bell
Discussion(0)
No comments yet. Be the first to comment.